EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway
European review for medical and pharmacological sciences (2019) - Comment
pubmed: 31599405  doi: 10.26355/eurrev_201909_18990  issn: 1128-3602  issn: 2284-0729 

H.-T. Fan, Y.-Y. Shi, Y. Lin, X.-P. Yang